The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
The latest news from CDMOs, CMOs, and suppliers featuring PharmaBlock Sciences, AGC Pharma Chemicals Europe, and Legacy Pharmaceutical Packaging.
Chemicals/Chemical API Manufacturing
PharmaBlock Launches Chemistry and Engineering Technology...
Samsung Biologics, a contract biologics manufacturer, and Vir Biotechnology, a San Francisco-based clinical-stage biopharmaceutical company, have formed a manufacturing agreement, valued at $362 million, under which Samsung Biologics will provide...
The latest news from CDMOs, CMOs, and suppliers featuring news from Univercells, Xellia, Aphena, and Cambrex.
Biologics Manufacturing
Univercells Launches CDMO Exothera Univercells, a technology company specializing in bioprocessing, has...
The latest from CDMOs, CMOs, and suppliers on supporting COVID-19 efforts featuring Cobra Biologics, Emergent Biosolutions, WuXi AppTec, Almac and Eurofins.
Biologics manufacturing
Cobra Biologics To Develop COVID-19 Vaccine Cobra Biologics, a...
Danaher, a global science and technology company, headquartered in Washington D.C., has completed its $21.4-billion acquisition of the biopharma business from General Electric’s Life Sciences division. As part of Danaher, the business will be...
The US Department of Health and Human Services (HHS) has launched a public–private partnership for high-speed, high-volume emergency drug-packaging using prefilled syringes and has awarded Apiject Systems America, a Stamford, Connecticut-based...
Thermo Fisher Scientific is investing more than $475 million in commercial capabilities and capacity in 2020 for biologics, cell and gene therapies, and drug products. This investment, in addition to those made in 2019, brings the total...
Fujifilm plans to invest approximately JPY 9 billion yen ($83 million) to expand microbial production capacity of Fujifilm Diosynth Biotechnologies (FDB), its CDMO of biologics, vaccines and gene therapies.
The expansion will triple FDB's...
Thermo Fisher Scientific has agreed to acquire Qiagen, a provider of molecular diagnostics and sample preparation technologies, for an approximate transaction value of $11.5 billion or EUR 39 ($44) per share.
The transaction values Qiagen at...
The latest news from CDMOs, CMOs, and suppliers featuring news from Dipharma, Fujifilm Diosynth Biotechnologies, Univercells, and Aphena Pharma Solutions.
Chemicals/Chemical API Manufacturing
Dipharma Completes Construction of New cGMP Suite in...
WuXi Vaccines, a vaccine CDMO and joint venture between WuXi Biologics and Shanghai Hile Bio-technology, has entered into a strategic partnership with an undisclosed global vaccine company and signed a 20-year vaccine manufacturing contract...
The latest news from CDMOs, CMOs, and suppliers featuring MilliporeSigma, A&C, Comar, Velesco, and ACG Inspection.
Chemicals/Chemical APIs
A&C Expands with New Bio Buffer Facility in Ireland
A&C, a manufacturer of excipients,...
The latest news from CDMOs, CMOs, and suppliers featuring Lonza, Vetter, LSNE, Azelis, and Hitachi Chemical Advanced Therapeutics.
Chemicals/Chemical API Manufacturing
Azelis India To Acquire S. Zheveri’s Distribution Business
Azelis, a provider...
Catalent has agreed to acquire MaSTherCell Global, a cell and gene therapy CDMO based in Gosselies, Belgium and Houston, Texas for $315 million in cash.
Founded in 2011, MasTherCell provides development and manufacturing services of...
The latest news from CDMOs, CMOs, and suppliers featuring news from Piramal, Just-Evotec Biologics, Cognate BioServices, Cobra Biologics, and Jones Healthcare Group.
Chemicals/Chemical API Manufacturing
Piramal Pharma Invests $19 M to Expand its...
